DECIPHER LABS LIMITED (DECIPHER.BO)
INR 11.69
(1.97%)
INR 11.69
(1.97%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 117.72 Million INR | 137.54% |
| 2022 | 49.56 Million INR | -72.13% |
| 2021 | 177.83 Million INR | -28.96% |
| 2020 | 250.34 Million INR | 9.7% |
| 2019 | 228.21 Million INR | 498.14% |
| 2018 | 38.15 Million INR | 353.24% |
| 2017 | 8.41 Million INR | 32.46% |
| 2016 | 6.35 Million INR | 31.01% |
| 2015 | 4.85 Million INR | 6.83% |
| 2014 | 4.54 Million INR | -46.26% |
| 2013 | 8.44 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -218.6 Million INR | -285.69% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 117.72 Million INR | 0.0% |
| 2023 Q2 | 33.31 Million INR | 0.0% |
| 2023 FY | 117.72 Million INR | 137.54% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 49.56 Million INR | 0.0% |
| 2022 Q2 | 89.07 Million INR | 0.0% |
| 2021 Q4 | 177.83 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 236.27 Million INR | 0.0% |
| 2020 Q4 | 250.34 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 194.35 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 33.44 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 228.21 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 67.43 Million INR | 0.0% |
| 2018 Q4 | 38.15 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q4 | 8.41 Million INR | 0.0% |
| 2017 Q3 | 8.41 Million INR | 12.9% |
| 2017 Q2 | 7.45 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q4 | 6.35 Million INR | 0.0% |
| 2016 Q2 | 7.81 Million INR | 0.0% |
| 2015 Q4 | 4.85 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q2 | 5.86 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2014 Q4 | 4.54 Million INR | 0.0% |
| 2014 Q2 | 6.12 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q1 | - INR | -100.0% |
| 2013 Q4 | 8.44 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Add-Shop E-Retail Limited | 159.2 Million INR | 26.054% |
| Concord Drugs Limited | 249.88 Million INR | 52.889% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | 27.184% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | 40.354% |
| Hindustan Bio Sciences Limited | 25.7 Million INR | -358.055% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | 41.602% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | 88.184% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 93.141% |
| Makers Laboratories Limited | 569.18 Million INR | 79.317% |
| Medi-Caps Limited | 63.01 Million INR | -86.818% |
| Parmax Pharma Limited | 117.56 Million INR | -0.134% |
| PRAVEG LIMITED | 767.53 Million INR | 84.662% |
| Sastasundar Ventures Limited | 1.5 Billion INR | 92.155% |
| Smruthi Organics Limited | 485.72 Million INR | 75.763% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 93.132% |
| Sunil Healthcare Limited | 902.83 Million INR | 86.96% |
| Syschem (India) Limited | 1.07 Billion INR | 89.005% |
| Transchem Limited | 6.72 Million INR | -1651.86% |
| Trinity League India Limited | 876 Thousand INR | -13338.927% |
| Tyche Industries Limited | 101.64 Million INR | -15.824% |
| Zenlabs Ethica Limited | 301.35 Million INR | 60.935% |
| Beryl Drugs Limited | 85.63 Million INR | -37.471% |
| ANG Lifesciences India Limited | 1.66 Billion INR | 92.915% |
| Bacil Pharma Limited | 1.12 Million INR | -10327.369% |
| BDH Industries Limited | 312.53 Million INR | 62.332% |
| Cian Healthcare Limited | 1.03 Billion INR | 88.618% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -5432.19% |
| Colinz Laboratories Limited | 24.1 Million INR | -388.384% |
| Mercury Laboratories Limited | 171.18 Million INR | 31.231% |
| Deccan Health Care Limited | 111.33 Million INR | -5.738% |
| Phaarmasia Limited | 211.49 Million INR | 44.337% |
| MedPlus Health Services Limited | 14.27 Billion INR | 99.175% |
| Parnax Lab Limited | 1.17 Billion INR | 89.944% |
| Patidar Buildcon Limited | 25.57 Million INR | -360.367% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | 24.08% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -39272.91% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -180.485% |
| Trident Lifeline Limited | 331.26 Million INR | 64.462% |
| Denis Chem Lab Limited | 289.82 Million INR | 59.38% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | 32.793% |
| Panchsheel Organics Limited | 340.2 Million INR | 65.396% |
| Zenith Healthcare Limited | 24.03 Million INR | -389.807% |
| Vivanza Biosciences Limited | 148.63 Million INR | 20.794% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -1226.927% |
| Vikram Thermo (India) Limited | 291.47 Million INR | 59.611% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -460.862% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -119.444% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | 88.278% |
| Roopa Industries Limited | 493.08 Million INR | 76.125% |
| PANJON LTD. | 25.38 Million INR | -363.795% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | 43.521% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -685.934% |
| Anuh Pharma Limited | 1.54 Billion INR | 92.378% |
| Crestchem Limited | 23.94 Million INR | -391.606% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -778.217% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | 0.421% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 93.675% |
| Trimurthi Limited | 101.36 Thousand INR | -116045.422% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | 41.713% |
| Norris Medicines Limited | 278.17 Million INR | 57.679% |
| Veerhealth Care Limited | 62.78 Million INR | -87.52% |
| Lactose (India) Limited | 536.39 Million INR | 78.053% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | 85.87% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 89.59% |
| Gennex Laboratories Limited | 535.21 Million INR | 78.004% |
| Godavari Drugs Limited | 957.86 Million INR | 87.71% |
| Zenotech Laboratories Limited | 156.64 Million INR | 24.847% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | 75.894% |
| Bharat Parenterals Limited | 2.65 Billion INR | 95.568% |
| Coral Laboratories Limited | 281.83 Million INR | 58.23% |
| Evoq Remedies Limited | 116.23 Million INR | -1.284% |
| Kerala Ayurveda Limited | 1.05 Billion INR | 88.869% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 94.238% |
| Natural Capsules Limited | 1.47 Billion INR | 92.031% |
| Auro Laboratories Limited | 433.09 Million INR | 72.818% |